Next Article in Journal
Application of Protein in Extrusion-Based 3D Food Printing: Current Status and Prospectus
Next Article in Special Issue
Chemical Characterization, α-Glucosidase, α-Amylase and Lipase Inhibitory Properties of the Australian Honey Bee Propolis
Previous Article in Journal
Application of Quantitative Microbiology and Challenge Tests to Reach a Suggested Food Safety Objective in a Middle Eastern-Style Ready-to-Cook Chicken Product
Previous Article in Special Issue
Chia (Salvia hispanica L.) Flour and Oil Ameliorate Metabolic Disorders in the Liver of Rats Fed a High-Fat and High Fructose Diet
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Review of the Phytochemistry and Bioactivity of Clover Honeys (Trifolium spp.)

1
Division of Pharmacy, School of Allied Health, University of Western Australia, Perth 6009, Australia
2
UWA School of Agriculture and Environment, University of Western Australia, Perth 6009, Australia
3
Cooperative Research Centre for Honey Bee Products Limited, 128 Yanchep Beach Road, Perth 6035, Australia
4
School of Biomedical Sciences, University of Western Australia, Perth 6009, Australia
*
Author to whom correspondence should be addressed.
Foods 2022, 11(13), 1901; https://doi.org/10.3390/foods11131901
Submission received: 25 May 2022 / Revised: 15 June 2022 / Accepted: 17 June 2022 / Published: 27 June 2022

Abstract

:
This review covers a comprehensive overview of the phytoconstituents and bioactivities reported to date for clover honeys produced from various Trifolium spp. against the backdrop of a more general discussion of the chemistry and bioactivity of these important agricultural species. While research into the phytochemical composition of various honeys and their associated bioactivities is growing, this review demonstrates that the literature to date has seen only a limited number of studies on clover honeys. Surprisingly, there appear to be no comparative data on the concentration of flavonoids in general or isoflavonoids specifically in different clover honeys, although the latter have been identified as a main group of bioactive compounds in red clover plants. Based on the findings of this review, the presence of phytoestrogenic isoflavonoids (e.g., formononetin, biochanin A, genistein, daidzein, glycitein) in clover plants and, by extension, in clover honeys should be further investigated, specifically of clover species outside the three popular perennial clovers (red, white and alsike clovers) to exploit new opportunities of potential benefit to both the pharmaceutical and apiculture industries.

1. Introduction

European honey bees (Apis mellifera) generate a variety of natural products of nutritional and in many instances also of medicinal value such as honey, but also bee pollen, propolis and royal jelly. Honey is a sweet and flavorful natural product that has been consumed for centuries for its high nutritive value but has also been used for thousands of years as a medicinal agent, with the earliest records of medicinal use dating back to the Ancient Egyptian era [1]. Honey products promote many beneficial human responses due to their bioactive constituents, including antimicrobial, antiviral, antioxidant, anti-inflammatory and antidiabetic effects [2,3]. Honey is a highly complex mixture of at least 200 phytochemicals with its composition being strongly influenced by multiple factors, including its botanical and geographical origin, the bee species involved in its production, its age, method of storage and processing [4,5].
Clover honeys, considered a premium product worldwide, are a unique type of honey produced from various species of the genus Trifolium [6]. Clovers are commonly a predominant species in multifloral honeys, indicating bee preference for these crops in an agricultural setting [7]. It is therefore no surprise that species such as T. incarnatum L. (crimson clover), T. pratense L. (red clover) and T. repens L. (white clover), but also T. michelianum Savi. (balansa clover), T. vesiculosum L. (arrowleaf clover) and T. fragiferum L. (strawberry clover) are all considered as being a relatively high value crop for honeybees [8].
Monofloral bioactive honeys are highly sought after and priced accordingly [9], as seen in the growing global demand for specialist pharmaceutical honeys such as the Manuka (Leptospermum scoparium) honey. There is also a strong impetus to develop various legume honeys into medicinal honeys [10]. Based on the plants’ well established phytochemical profile, clover honeys could indeed be a potential source of bioactive honeys. In this context, integrated studies on the chemical composition and biological activity of clover honeys will be very important in establishing their potential therapeutic applications.
In support of this call for more research on clover honeys, this review focuses on the physicochemical characteristics, key phytochemical constituents and different bioactivities reported for clover honeys of different botanical origins. Against the backdrop of a brief review of honey chemistry in general as well as a short discussion of the clover plant genus, a systematic literature review is presented on the body of peer-reviewed scientific research on clovers and their interaction with European honeybees. To compile this review, the data bases PubMed®, ScienceDirect™ and Google Scholar were searched between January 2022 and February 2022 using different combinations of the following terms: ‘clover’, ‘clover honey’, ‘chemistry of clover honey’, ‘bioactivity of clover honey’ “Apis mellifera”, and ‘European honeybee’. Multiple clover species names were identified during the search and confirmed through consultation with specialists in legume research at The University of Western Australia and the Department of Primary Industries and Regional Development (DPIRD). Titles and abstracts obtained in this primary literature search were considered to select articles for full review, and the reference sections from each article was subsequently searched for related publications of interest.

2. The Chemistry of Honey

Honey is a highly concentrated complex mixture of mainly sugars (75–85%), water (13–20%) and a small fraction of non-sugar constituents (approx. 3%) [4,5,8,11]. The principal carbohydrate constituents of honey are fructose (approx. 33 to 38%) and glucose (approx. 28 to 31%), which represent 85–95% of total sugars that are readily absorbed in the gastrointestinal tract [12,13]. Other sugars include disaccharides, such as maltose, sucrose, isomaltose, turanose, nigerose, melibiose, panose, maltotriose and melezitose, as well as 4 to 5% fructooligosaccharides, which can serve as prebiotic agents [13,14]. Honey’s non-sugar constituents, though only present in relatively small quantities, are considered to be vital in influencing not only its organoleptic and physicochemical characteristics but also its bioactivity profile [15]. Organic acids constitute approximately 0.6% of honey and include, amongst others, gluconic acid, which is a by-product of enzymatic digestion of glucose. The organic acids are responsible for the acidity of honey, resulting typically in a pH range of 3–5, and contribute largely to its characteristic taste [16]. The concentration of mineral compounds in honey ranges from 0.1% to 1.0%. Potassium is the major metal, followed by calcium, magnesium, sodium, sulphur and phosphorus. Trace elements include iron, copper, zinc and manganese [17,18,19]. Nitrogenous compounds, vitamins C and B1 (thiamine), and B2 complex vitamins like riboflavin, nicotinic acid, vitamin B6 and pantothenic acid are also present [16]. Furthermore, honey contains proteins, but only in minute quantities (0.1–0.5%) [20,21]. Plant pollen, a natural contaminant found in honey as a result of bees’ foraging activities, contributes significantly to honey’s overall protein content [2,7,9]. In addition, according to a recent report, specific protein quantities in honey also differ depending on the species of honeybee producing the honey [22], since honey’s protein content is also related to the presence of a variety of bee enzymes. The main enzymes found in honeybee derived honeys are glucose oxidase, invertase (saccharase), diastase (amylase) and catalase. They play an important role in the composition and, in parts, also the bioactivity of honey [16]. Glucose oxidase, for example, is important as it produces hydrogen peroxide, which provides the honey with antimicrobial properties, as is gluconic acid, which aids calcium absorption in humans. Invertase, on the other hand, converts sucrose to fructose and glucose, while dextrin and maltose are produced from long starch chains by the activity of amylase. Catalase generates oxygen and water from hydrogen peroxide and its presence thus has a negative effect on a honey’s hydrogen peroxide-related antibacterial activity [23].

3. Clover Honeys

Clover is the common name used for plants of the genus Trifolium, which includes both annual and perennial species. They are short leguminous herbs with trifoliate leaves and compact flower heads and include numerous important crops for pasture animal forage, which are also alluring to bees. Clover plants belong to the large and economically important family of Fabaceae or Leguminosae, one of the largest families of flowering plants [24], and the third biggest land-based plant family, comprising 730 genera and over 19,400 species [25]. Of all the plants that humans currently use as a food source, perhaps only grasses (Gramineae) exceed the importance of legumes [26]. Many of the Trifolium species are cultivated extensively as fodder plants and, like other members of the legume family, they naturally add nitrogen to the soil, a process known as biological nitrogen-fixation. Legumes also add other value in terms of weed, insect, and pathogen control and in increasing soil organic matter when rotated with crops in farming systems [27].
Research has demonstrated that Trifolium spp. exhibit a range of biological effects, including antioxidant, anticestodal, anti-inflammatory, cytotoxic, cytostatic and estrogenic activities. They are thus popular in some traditional medicinal applications and used, for instance, as chemoprotective agents against cancers and cardiovascular diseases [28,29,30]. In recent decades, several studies have established the nutritious value and bioactive compounds in various members of the Fabaceae, including red clover [31,32,33,34]. A range of isoflavonoids alongside volatile and fatty oils, vitamin C and carotene have been identified from the flower heads and leaves of red clover. Being rich in isoflavones, red clover has been found to be able to prevent several conditions and diseases [34,35,36]. Secondary metabolites isolated from its flower heads have, for example, been demonstrated to possess beneficial effects in the management of menopausal disorders, cardiovascular diseases and several cancers [37,38,39]. Menopause, an intermediate phase from a reproductive to a non-reproductive period in a woman’s life, is characterised by a decrease in estrogen, which triggers a range of uncomfortable symptoms including hot flushes, night sweats, cognitive change, anxiety, depression, sleep disturbances and vaginal dryness [40,41,42], which can significantly affect quality of life. The use of red clover in the treatment of menopausal symptoms is popular, based on the general premise that isoflavones (e.g., formononetin, genistein, daidzein, and biochanin A) will act as a natural estrogen replacement in menopausal women and thus alleviate climacteric symptoms [31,39]. Moreover, phytoestrogens and other flavonoids found in red clover are effective antioxidants and may have tyrosine kinase inhibitory activity [42].
Clovers are a prolific source of pasture honeys, which are characterised by a strong nectar aroma and a light nectar flavour. The aerial clovers also often have uncovered anthers and stigmas in the flowers, offering a floral morphology that is functionally well suited to pollination by honey bees [43]. Inflorescences are usually branched racemes or panicles, providing a high number of flowers per planting area that attracts pollinators [44]. The most important clovers for honey production to date are red clover, white or Dutch clover, alsike clover (T. hybridum) and crimson clover (T. incarnatum). The honeys harvested from these species are mainly appreciated for their distinct and complex flavour profiles.
Although some clover honeys are already produced commercially, very little is known about their phytochemical profile. For the vast majority of the about 100 different Trifolium species in the Australian Pastures Genebank, for example, no data is yet available on the honeys that might be produced from them, such as their phytochemical characteristics and bioactivities. To address this gap in knowledge, in this study we present information pertaining to the phytochemistry of different clovers followed by a review of the scarce literature on clover honeys.

3.1. Phytochemical Composition and Bioactivity of Clover Plants

Kaurinovic et al. [42] investigated the presence of phenolic compounds in T. pratense leaf extracts and found, not surprisingly, that the extraction solvent played an important role, with the ethyl acetate extracts yielding the highest total phenolic content (0.43 ± 0.01 mg gallic acid equivalents (GAE)/g dry extract (d.e.). A significant amount of phenolic compounds was also observed in the aqueous extract (0.34 ± 0.03 mg GAE/g d.e.) whereas the amounts of total phenolics found in the diethyl ether and n-butanol extracts were lower, at 0.22 ± 0.03 mg GAE/g d.e. and 0.21 ± 0.03 mg GAE/g d.e., respectively. A considerable total flavonoids content was also determined in the aqueous (15.13 ± 0.05 µg rutin equivalents (RE)/g d.e.) and ethyl acetate (15.23 ± 0.01 µg RE/g d.e.) extracts [37], less so in the n-butanol (11.87 ± 0.03 µg RE/g d.e.) extracts, and the smallest quantities of total flavonoids were recovered from the diethyl ether (11.78 ± 0.04 µg RE/g d.e.) and chloroform extracts (9.24 ± 0.03 µg RE/g d.e) [42]. Next to the chosen extraction solvent, the presence and concentration of secondary metabolites like flavonoids mainly depend on the plant’s development stage, its genotype, as well as the plant part itself, so concentrations of bioactive constituents vary considerably between stems, leaves and flowers [31,45,46].
Approximately 40 different isoflavones have to date been reported from red clover plants [47,48], the main ones being biochanin A and formononetin, along with lower concentrations of daidzein, glycitein and genistein (Table 1 and Figure 1) [49,50,51]. Other isoflavones (Table 1 and Figure 1 and Figure 2) found in the leaves of red clover plants include calycosin, prunetin, afrormosin, texasin, irilin B, irilone and pseudobaptigenin, which were identified through several studies [52,53,54] alongside other flavonoids such as quercetin and kaempferol (Table 2, Figure 3). Furthermore, red clover is characterised by the presence of other phenolics, in particular phenolic acids such as caffeic, rosmarinic and chlorogenic acid (Table 3 and Figure 4) [42]. Other clover plants, for example alsike clover, have also been found to contain phenolic constituents along with other compounds. High Performance Liquid Chromatography (HPLC) analyses of ethanolic extracts of alsike clover flowers have identified chlorogenic acid, cryptochlorogenic acid, p-coumaric acid, quercetin, gallic acid, syringic acid and catechin (Table 2, Table 3 and Table 4 and Figure 3, Figure 4, Figure 5 and Figure 6) [55]. Quercetin was the major phenolic compound detected and found to be responsible for several bioactivities (e.g., antioxidant, antimicrobial activity etc.) in alsike clover flowers [55,56]. Their antioxidant activity was confirmed in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, where DPPH is used as a stable free radical to capture the antiradical activity of honey and a dose-dependent antimicrobial activity against bacteria (E. coli, Salmonella typhi, Bacillus aureus, S. aureus), yeast (C. albicans) and fungi (Aspergillus flavus) was also reported [55].
In addition to some phenolic constituents, volatile components present in different clover species have also been determined. A study, carried out by Massei et al. [57], identified volatile components (Table 5 and Figure 7) in red clover, strawberry clover and white clover. (E)-3-Hexenyl acetate and (E)-3-hexenol were present in all three species, but in substantially larger amounts in white clover. Two major volatiles of white clover, 2-propanone and 2-butanone, were found only in this species. These two key volatiles were found to be released in significant quantities from the oil extract alongside smaller amounts of (E)-3-hexenal, 1-octen-3-ol and (E)-3-hexenyl acetate as well as (E)-3-hexenol, which was produced by damaging the growing plant [58]. It has also been found that white clover contains cyanogenic glycosides, which liberate toxic levels of hydrogen cyanide (HCN) and so provide an immediate chemical defense response to herbivores and pathogens causing damage [30].
In summary, the review of the literature has unveiled several studies reporting biological activities for red and alsike clovers [28,29,30], though other Trifolium spp. are also used as medicinal plants. Red clover extracts are, for example, taken internally for the treatment of skin complaints (especially eczema and psoriasis), cancers of the breast, ovaries and lymphatic system, chronic degenerative diseases, gout, whopping cough and dry coughs [59]. Extracts of red clover are also becoming increasingly popular for the treatment of menopausal symptoms [60,61,62]. Furthermore, phytoestrogens present in red clover are also effective antioxidants and may have tyrosine kinase inhibitory activity. The antioxidant properties of genistein and other phytoestrogens have, for example, been demonstrated in vitro in several models such as protection from phorbol ester-induced singlet oxygen or peroxide formation and particularly from UV-radiation induced oxidative damage to DNA [63,64,65]. In animal models, particularly in mice, dietary genistein has been shown to stimulate the endogenous antioxidants superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and glutathione reductase (GSHR) as well as glutathione S-transferase, with the antioxidant effects (i.e., protection against free radical-induced cell damage by metabolizing oxidative toxic intermediates) seen mainly in the small intestine and the skin [66,67].

3.2. Phytochemical Composition of Clover Honey

There is an increasingly positive market trend for honey products with medicinal benefits within the retail and pharmaceutical industry following in particular the success of the highly antibacterial New Zealand Manuka honey. While research into the phytochemical composition of various honeys and their associated bioactivities is growing, the literature to date has seen only a limited number of studies on clover honeys. Surprisingly, there appear to be no comparative data on the concentration of flavonoids in general or isoflavonoids specifically in different clover honeys although the latter have been identified as the main group of bioactive compounds in red clover plants. The presence of phenolic acids and flavonoid compounds, specifically isoflavones, in clover honeys is, however, to be expected, given that honeybees collect nectar from clover flowers that have been shown to contain these potentially bioactive compounds [68,69,70,71].
With respect to other phenolic compounds, high performance liquid chromatography-pulsed amperometric detection (HPLC-PAD) analysis of Polish sweet clover honey (Melilotus officinalis L.), for example, has indicated the presence of 15 phenolic compounds, nine of them phenolic acids (Table 3 and Table 4 and Figure 4, Figure 5 and Figure 6) (caffeic, rosmarinic, p-coumaric, ferulic, cinnamic, gallic, p-hydroxybenzoic, m-hydroxybenzoic, ellagic) and six flavonoids (Table 1 and Table 2 and Figure 1, Figure 3 and Figure 6) (genistein, quercetin, morin, myricetin, pinocembrin, (+)-catechin) [72]. Among these 15 phenolic compounds, the amounts of gallic acid (23.23 ± 4.52 mg/100 g honey) and (+)-catechin (26.79 ± 2.99 mg/100 g honey) present were considered significant [72]. Moreover, gas chromatography-mass spectrometry (GC-MS) analysis of dichloromethane extracts, obtained after steam distillation, Soxhlet extraction, and ultrasonic solvent extraction (USE) of Polish sweet yellow clover honey led to the identification of a range of volatile compounds (Table 5 and Figure 8). When using the steam distillation technique, β-phellandrene (2.17%), benzenacetaldehyde (5.84%), β-menthane (2.23%), thymol (2.03%) and ethyl 2-(5-methyl-5-vinyltetrahydrofuran-2-yl) propan-2-ylcarbonate (2.84%) were detected. Soxhlet extraction yielded carophyllene (11.23%), 13-epimanool (1.45%), phenylacetic acid (5.35%) and p-eugenol (6.54%), and phenylethyl alcohol (2.03%), while the predominant compounds isolated using USE were phenylacetic acid (25.54%), α-(phenylmethyl) benzenethanol (6.44%) and p-acetoxyanisole (2.89%). In the case of solid phase extraction (SPE), two major compounds were identified, phenylacetic acid (13.04%) and N-butylbenzensulfonamide (10.94%) [72]. Coumarin and lumichrome (Table 5 and Figure 9), a breakdown product of riboflavin, which forms in the presence of light in neutral or acidic solutions, were also isolated from Polish sweet yellow clover honeys using the SPE method. The authors suggest that the presence of coumarin in sweet yellow clover honey might be used as a marker to authenticate the honey’s floral source alongside the presence of lumichrome and a high concentration of phenylacetic acid [68,72].
p-Coumaric acid was detected as the main phenolic component in the ethanol extract of alsike clover honey [55]. It is responsible for the honey’s characteristic sweet odour and has been linked to some health-promoting properties, including sedative, spasmolytic, anti-inflammatory and antithrombotic activities. It is proposed to strengthen lymphatic vessels, stimulate blood and lymph flow and for that reason alsike clover honey is suggested to be used in the prophylaxis and treatment of lymphedema as well as chronic venous disease (CVD) [69,70,71]. Similar to the flower extract of alsike clover, the HPLC analysis of the honey’s ethanolic extract also revealed the presence of quercetin, chlorogenic acid, cryptochlorogenic acid, p-coumaric acid, gallic acid, syringic acid and catechin [55].
Volatile constituents of red clover honey were investigated by Jerkovic et al. [38]. They identified 12 compounds (Table 5 and Figure 10) by headspace solid-phase micro-extraction (HS-SPME) [38]. The dominant compounds were lilac aldehyde isomers ranging individually from 7.6% to 21.4%. Other major compounds were benzene derivatives such as phenylacetaldehyde (10.1–31.2%) and benzaldehyde (7.0–15.7%) [38]. The authors concluded that an abundance of lilac aldehydes together with phenylacetaldehyde and benzaldehyde can be considered as the typical volatile profile of red clover honey [38]. These volatile constituents have frequently been found in honey and have been demonstrated to originate from phenylalanine as a precursor compound [73]. Two lower molecular weight aliphatic acids were also found during the headspace analysis of red clover, namely octanoic acid (0.7–2.9%) and nonanoic acid.
A range of acidic constituents (Table 5 and Figure 11) have been isolated and identified from extracts of aqueous solutions of white clover honey by Tan et al. [74]. Next to hydrocarbons (C21–C33), they reported the presence of a variety of straight-chain monoacidic compounds (C8–C28). Palmitic, lignoceric, oleic and α-linolenic acid were dominant in content alongside diacid (succinic acid, octanedioic, decanedioic, 2-decenedioic, nonanedioic acids) and aromatic compounds (2-hydroxy-3-phenylpropionic acid, (E)-cinnamic acid, phenylacetic acid, and benzoic acid) [74].
Minerals and trace elements in clover honeys have also been reported. Though not a legume per se, a study conducted by Zaghloul et al. [75] on ‘Brazilian Clover’ (Richardsonia brasiliensis) honey reported that potassium was the most abundant element (306.600 mg/100 g). In addition, the honey was also found to contain other minerals such as Ca, Na, Mg, Zn, Cu, Fe, Mn and Pb [75].
Hydroxymethyl furfural (HMF) (Table 5 and Figure 9) is an important indicator in evaluating the freshness of honey [76,77], as it can be formed as a heat-triggered degradation product of monosaccharides. Thus, the formation of HMF is affected by many factors such as a honey’s fructose content, the type of other sugars present, its fructose to glucose ratio, storage and other treatment temperatures, pH, the age of the honey and ultimately its floral source [77,78]. A comparative chemical analysis of Brazilian pepper, clover and citrus honeys was conducted by Zaghloul et al. [75]. Data revealed that clover honey contained high levels of HMF (77.13 mg/kg), while Citrus honey had the lowest content (10.73 mg/kg) [75]. It is not clear, however, from the findings of this study, if higher HMF levels are an inherent feature of clover honeys or if these results were triggered by specific handling, processing and storage conditions. Since HMF is associated with potentially negative health outcomes [79,80], its presence in honey is limited by the Codex Alimentarius to 40 mg/kg [72,81]. However, in the case of honeys of declared origin from countries or regions with tropical ambient temperatures, and blends of these honeys, the HMF content shall not exceed 80 mg/kg [72,81]. The collation of more data on typical HMF concentrations in different clover honeys should therefore be a focus of future research.

3.3. Bioactivity of Clover Honeys

A review of the literature on the chemistry of clover honeys has only been able to identify limited studies that reported on the phytochemical constituents of these honeys. Similarly, to date, only a few studies have investigated the bioactivities (Table 6) of clover honeys. These studies are briefly discussed in the following section.
Without focusing on specific individual compounds, a study conducted by Smetanska et al. [82] revealed that the total phenolic content in Egyptian clover honey (T. alexandrinum L.), determined using the Folin Ciocalteau method, varied from 18.574 mg to 53.314 mg gallic acid equivalent/g honey. Similarly, the authors also investigated the total flavonoid content in Egyptian clover honey by a complexation reaction with AlCl3 and found it to be 26.604 mg catechin/kg honey [82]. By extension, these unspecific quantifications can be seen as a broad assessment of the antioxidant activity of Egyptian clover honey.
More specific bioactivity studies to date have mainly investigated the antioxidant and antimicrobial activities of honeys. In the case of red clover honeys, they have been found in two studies to exhibit antioxidant activity to different degrees [38,82]. In one, red clover honey showed moderate radical scavenging activity in the DPPH assay, where DPPH (2,2-diphenyl-1-picrylhydrazyl) is used as a stable free radical to capture the antiradical activity of honey [38]. In another study that employed the ferric-reducing antioxidant power (FRAP) assay, another widely applied method for the determination of total antioxidant activity of natural products including honeys [33], Jerkovic et al. [38] reported a weak antioxidant activity for red clover honey.
Honey has also been known since ancient times as a therapy for infected wounds. In clinical practice today honey is used as a topical wound treatment, especially for those wounds that do not respond to conventional therapies, such as diabetic ulcers [83,84]. Diabetic foot infection, most commonly with Proteus mirabilis, is a serious complication of diabetes that can lead to amputation of the lower extremities. The infection is problematic to treat due to the high resistance to antibiotics and biofilm formation. Egyptian clover honey was found to exert antibacterial activity against P. mirabilis at an aqueous concentration of 40% (w/v) and to completely inhibit the swarming motility of P. mirabilis at 20% (w/v) concentration [85]. Its activity was deemed to be bactericidal since its Minimum Bactericidal Concentration (MBC)/Minimum Inhibitory Concentration (MIC) was equivalent to 1 [85]. Moreover, P. mirabilis was also shown to be inhibited by Egyptian clover honey at a concentration of 35% (w/v) [86], which confirms the antimicrobial activity of this honey as reported by others [85]. Translating these findings into practice, the application of Egyptian clover honey dressings in a clinical trial involving 30 patients with infected diabetic foot ulcers was found to result in the complete healing of 43.3% of ulcers, significant reduction in ulcer size for 43.3% of patients, and a lowering of the bacterial burden in all ulcers after the first week of therapy [87].
Furthermore, the antimicrobial effects of alsike clover honey were investigated by Roby et al. [55], who reported activity against bacteria (Escherichia coli, Salmonella typhi, Bacillus cereus, Staphylococcus aureus), one strain of yeast (Candida albicans), and one strain of fungi (Aspergillus flavus). In a separate study conducted by Khairy et al. [86], clover honey (regrettably the specific botanical Trifolium species was not stipulated) demonstrated also good antibacterial activity against Pseudomonas aeruginosa and S. aureus. Similarly, Egyptian clover honey at an aqueous concentration of 20.3% (w/v) inhibited the growth of S. aureus, P. aeruginosa and Klebsiella pneumoniae [88].
Outside the medical field, clover honeys have also been investigated for potential applications. Corrosion is a natural process commonly defined as the deterioration of metal surfaces caused by reaction with the surrounding environment. A common method for corrosion control and prevention is to apply corrosion inhibitors. Most commercial corrosion inhibitors are expensive and are health and environmental hazards. In recent years, the focus has been directed towards exploring naturally occurring materials and their extracts to produce cheaper, non-toxic, and “green” corrosion inhibitors. Due to its biodegradability, eco-friendliness and low cost, honey with its antioxidant activity may fulfil the requirements of a non-toxic natural corrosion inhibitor. Several studies have already confirmed the potential application of honey as an inhibitor of corrosion in different metals and alloys [89,90,91,92,93]. Aluminium and its alloys are the most used materials in the food, pharmaceutical and cosmetics industries. In one study, the anticorrosive properties of red clover honey on aluminium AA 2017A alloy in NaCl solution (0.1 mol L−1), as determined by potentiodynamic polarization and potentiostatic pulse measurements, was found to be significant, indicating its potential as a new “green” corrosion inhibitor [38].

4. Conclusions

This comprehensive review presents the physicochemical characteristics, phytochemical constituents as well as bioactivities of clover honeys and clover plants around the globe. The literature review found numerous articles on red, white and alsike clovers, which are perennials (or short-lived perennials) and are traditionally grown in the high-rainfall regions of Europe and North America. This is not surprising, as the red and white clovers are the most widely cultivated perennial species used as fodder plants in the world. There are, however, numerous other aerial annual Trifolium species adapted to a broad range of soil types and rainfall zones that are not adequately covered by the current literature. These species have remained largely unassessed as pollen or nectar sources for the apicultural industry, and their bioactivity is underexplored as potential sources of new natural medicines.
Trifolium spp. are known to be a potent natural source of isoflavonoids used in traditional medicine to treat a number of health disorders. Red clover, for instance, has gained much popularity due to research into its use for the treatment for menopausal symptoms. The presence of unique isoflavonoids (e.g., formononetin, biochanin A, genistein, daidzein, glycetein) in clover plants and, by extension, in clover honeys might differentiate these in providing specific bioactivities (e.g., phytoestrogenic activity) that should be further investigated. Based on the findings of this comprehensive literature review, a more in-depth exploration is warranted, in particular of clover species outside the three popular perennial clovers (red, white and alsike clovers) to exploit new opportunities of potential benefit to both the pharmaceutical and apiculture industries.

Author Contributions

Conceptualization, S.S. and C.L.; methodology, S.S., C.L. and K.F.; writing-original draft preparation, S.S.; writing-review and editing, C.L., K.F. and L.Y.L.; supervision, C.L., L.Y.L., K.H. and K.F.; project administration, C.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that they have no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Saranraj, P.; Sivasakthi, S.; Feliciano, G. Pharmacology of honey: A review. Biol. Res. 2016, 10, 271–289. [Google Scholar]
  2. Gomes, S.; Dias, L.G.; Moreira, L.L.; Rodrigues, P.; Estevinho, L. Physicochemical, microbiological and antimicrobial properties of commercial honeys from Portugal. Food Chem. Toxicol. 2010, 48, 544–548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Fedorova, A.A.; Azzami, K.; Ryabchikova, E.I.; Spitsyna, Y.E.; Silnikov, V.N.; Ritter, W.; Gross, H.J.; Tautz, J.; Vlassov, V.V.; Beier, H.; et al. Inactivation of a nonenveloped RNA virus by artificial ribonucleases: Honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment. Antivir. Res. 2011, 91, 267–277. [Google Scholar] [CrossRef] [PubMed]
  4. Al-Farsi, M.; Al-Amri, A.; Al-Hadhrami, A.; Al-Belushi, S. Color, flavonoids, phenolics and antioxidants of Omani honey. Heliyon 2018, 4, e00874. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Hossain, M.L.; Lim, L.Y.; Hammer, K.; Hettiarachchi, D.; Locher, C. Honey-based medicinal formulations: A critical review. Appl. Sci. 2021, 11, 5159. [Google Scholar] [CrossRef]
  6. Abell, D.C.; Friebe, H.; Schweger, C.; Kwok, A.S.K.; Sporns, P. Comparison of processed unifloral clover and canola honey. Apidologie 1996, 27, 451–460. [Google Scholar] [CrossRef] [Green Version]
  7. Primorac, L.; Bubaloa, D.; Kenjeric, D.; Flanjak, I.; Piricki, A.P.; Mandic, M.L. Pollen spectrum and physicochemical characteristics of Croatian Mediterranean multifloral honeys. Dtsch. Lebensm. 2008, 104, 170–175. [Google Scholar]
  8. SARE. 2015. Available online: https://www.sare.org/resources/cover-cropping-for-pollinators-and-beneficial-insects/ (accessed on 20 April 2022).
  9. Ciappini, M.; Vitelleschi, M.; Calviño, A. Chemometrics classification of Argentine clover and eucalyptus honeys according to palynological, physicochemical, and sensory properties. Int. J. Food Prop. 2016, 19, 111–123. [Google Scholar] [CrossRef]
  10. Oryan, A.; Alemzadeh, E.; Moshiri, A. Biological properties and therapeutic activities of honey in wound healing: A narrative review and meta-analysis. J. Tissue Viability 2016, 25, 98–118. [Google Scholar] [CrossRef]
  11. Bueno-Costa, F.M.; Zambiazi, R.C.; Bohmer, B.W.; Chaves, F.C.; Silva, W.P.D.; Zanusso, J.T.; Dutra, I. Antibacterial and antioxidant activity of honeys from the state of Rio Grande do Sul, Brazil. LWT—Food Sci. Technol. 2016, 65, 333–340. [Google Scholar] [CrossRef] [Green Version]
  12. Moundoi, M.A.; Padila-Zakour, O.I.; Worobo, R.W. Antimicrobial activity of honey against food pathogens and food spoilage microorganisms. NYSAES 2001, 1, 61–71. [Google Scholar]
  13. Ezz El-Arab, A.M.; Girgis, S.M.; Hegazy, E.M.; Abd El-Khalek, A.B. Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice. BMC Complement. Altern. Med. 2006, 6, 6. [Google Scholar] [CrossRef] [PubMed]
  14. Chow, J. Probiotics and prebiotics: A brief overview. J. Ren. Nutr. 2002, 12, 76–86. [Google Scholar] [CrossRef]
  15. Nguyen, H.T.L.; Panyoyai, N.; Kasapis, S.; Pang, E.; Mantri, N. Honey and its role in relieving multiple facets of atherosclerosis. Nutrients 2019, 11, 167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Olaitan, P.B.; Adeleke, E.O.; Ola, O.I. Honey: A reservoir for microorganisms and an inhibitory agent for microbes. Afr. Health Sci. 2007, 7, 159–165. [Google Scholar] [PubMed]
  17. Sampath Kumar, K.P.; Bhowmik, D.; Biswajit, C.; Chandira, M.R. Medicinal uses and health benefits of honey: An overview. J. Chem. Pharm. Res. 2010, 2, 385–395. [Google Scholar]
  18. Rashed, M.N.; Soltan, M.E. Major and trace elements in different types of Egyptian mono-floral and non-floral bee honeys. J. Food Compos. Anal. 2004, 17, 725–735. [Google Scholar] [CrossRef]
  19. Lachman, J.; Kolihová, D.; Miholová, D.; Košata, J.; Titěra, D.; Kult, K. Analysis of minority honey components: Possible use for the evaluation of honey quality. Food Chem. 2007, 101, 973–979. [Google Scholar] [CrossRef]
  20. Lee, D.C.; Lee, S.Y.; Cha, S.H.; Choi, Y.S.; Rhee, H.I. Discrimination of native bee-honey and foreign bee-honey by SDS–PAGE. Korean J. Food Sci. 1998, 30, 1–5. [Google Scholar]
  21. Jagdish, T.; Joseph, I. Quantification of saccharides in multiple floral honeys using fourier transform infrared microattenuated total reflectance spectroscopy. J. Agri. Food Chem. 2004, 52, 3237–3243. [Google Scholar]
  22. Won, S.R.; Li, C.Y.; Kim, J.W.; Rhee, H.I. Immunological characterization of honey major protein and its application. Food Chem. 2009, 113, 1334–1338. [Google Scholar] [CrossRef]
  23. Bansal, V.; Medhi, B.; Pandhi, P. Honey—A remedy rediscovered and its therapeutic utility. Kathmandu Univ. Med. J. 2005, 3, 305–309. [Google Scholar]
  24. Sprent, J.I. Nodulation in Legumes; Royal Botanic Gardens, Kew: London, UK, 2001. [Google Scholar]
  25. Lewis, G.P.; Schrire, B.D.; MacKinder, B.A.; Lock, J.M. Legumes of the World; Royal Botanic Gardens, Kew: London, UK, 2005. [Google Scholar]
  26. Graham, P.H.; Vance, C.P. Legumes: Importance and constraints to greater use. Plant Physiol. 2003, 131, 872–877. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. O’Hara, G.W.; Howieson, J.G.; Graham, P.H. Nitrogen fixation and agricultural practice. In Nitrogen Fixation in the Millennium; Leigh, G.J., Ed.; Elsevier: Amsterdam, The Netherlands, 2002; pp. 391–410. [Google Scholar]
  28. Sabudak, T.; Dokmeci, D.; Ozyigit, F.; Isik, E.; Aydogdu, N. Anti-inflammatory and antioxidant activities of Trifolium resupinatum var. microcephalum extracts in arthritic rats. Asian J. Chem. 2008, 20, 1491–1496. [Google Scholar]
  29. Sabudak, T.; Ozturk, M.; Goren, A.C.; Kolak, U.; Topcu, G. Fatty acids and other lipid composition of five Trifolium species with antioxidant activity. Pharm. Biol. 2009, 47, 137–141. [Google Scholar] [CrossRef] [Green Version]
  30. Kolodziejczyk-Czepas, J. Trifolium species-derived substances and extracts-biological activity and prospects for medicinal applications. J. Ethnopharmacol. 2012, 143, 14–23. [Google Scholar] [CrossRef]
  31. Saviranta, N.M.M.; Anttonen, M.J.; von Wright, A.; Karjalainen, R.O. Red clover (Trifolium pratense L.) isoflavones: Determination of concentrations by plant stage, flower colour, plant part and cultivar. J. Sci. Food Agric. 2008, 88, 125–132. [Google Scholar] [CrossRef]
  32. Gaweł, E. Chemical composition of lucerne leaf extract (EFL) and its applications as a phytobiotic in human nutrition. Acta Sci. Pol. Technol. Aliment. 2012, 11, 303–310. [Google Scholar]
  33. Ince, S.; Ekici, H.; Yurdakok, B. Determination of in vitro antioxidant activity of the sainfoin (Onobrychis viciifolia) extracts. Ankara Univ. Vet. Fak. Derg. 2012, 59, 23–27. [Google Scholar]
  34. Lindström, B.E.M.; Frankow-Lindberg, B.E.; Dahlin, A.S.; Wivstad, M.; Watson, C.A. Micronutrient concentrations in relation to phenological development of red clover (Trifolium pratense L.), perennial ryegrass (Lolium perenne L.) and timothy (Phleum pratense L.). Grass Forage Sci. 2014, 69, 276–284. [Google Scholar] [CrossRef]
  35. Atkinson, C.; Compston, J.E.; Day, N.E.; Dowsett, M.; Bingham, S.A. The effects of phytoestrogen isoflavones on bone density in women: A double-blind, randomised, placebo-controlled trial. Am. J. Clin. Nutr. 2004, 79, 326–333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Miadokova, E. Isoflavonoids—An overview of their biological activities and potential health benefits. Interdiscip. Toxicol. 2009, 2, 211–218. [Google Scholar] [CrossRef] [PubMed]
  37. Drenin, A.A.; Botirov, E.K.; Turov, Y.P. A new isoflavone glycoside from Trifolium pratense L. Russ. J. Bioorg. Chem. 2011, 37, 862–865. [Google Scholar] [CrossRef]
  38. Jerković, I.; Radonić, A.; Kranjac, M.; Zekić, M.; Marijanović, Z.; Gudić, S.; Kliškić, M. Red clover (Trifolium pratense L.) honey: Volatiles chemical-profiling and unlocking antioxidant and anticorrosion capacity. Chem. Pap. 2016, 70, 726–736. [Google Scholar] [CrossRef]
  39. Mu, H.; Bai, Y.H.; Wang, S.T.; Zhu, Z.M.; Zhang, Y.W. Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover). Phytomedicine 2009, 16, 314–319. [Google Scholar] [CrossRef]
  40. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.A.; Howard, B.V.; Johnson, K.C.; et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. JAMA 2002, 288, 321–333. [Google Scholar]
  41. Dalal, P.K.; Agarwal, M. Postmenopausal syndrome. Indian J. Psychiatry 2015, 57 (Suppl. 2), S222–S232. [Google Scholar] [CrossRef]
  42. Kaurinovic, B.; Popovic, M.; Vlaisavljevic, S.; Schwartsova, H.; Vojinovic-Miloradov, M. Antioxidant profile of Trifolium pratense L. Molecules 2012, 17, 11156–11172. [Google Scholar] [CrossRef] [Green Version]
  43. Palmer, R.G.; Perez, P.T.; Ortiz-Perez, E.; Maalouf, F.; Suso, M.J. The role of crop-pollinator relationships in breeding for pollinator-friendly legumes: From a breeding perspective. Euphytica 2009, 170, 35–52. [Google Scholar] [CrossRef] [Green Version]
  44. Kunin, W.E. Population size and density effects in pollination: Pollinator foraging and plant reproductive success in experimental arrays of Brassica kaber. J. Ecol. 1997, 85, 225–234. [Google Scholar] [CrossRef]
  45. Sivesind, E.; Seguin, P. Effects of the environment, cultivar, maturity, and preservation method on red clover isoflavone concentration. J. Agric. Food Chem. 2005, 53, 6397–6402. [Google Scholar] [CrossRef] [PubMed]
  46. Oleszek, W.; Stochmal, A.; Janda, B. Concentration of isoflavones and other phenolics in the aerial parts of Trifolium Species. J. Agric. Food Chem. 2007, 55, 8095–8100. [Google Scholar] [CrossRef] [PubMed]
  47. Klejdus, B.; Vitamvásová-Štěrbová, D.; Kubáň, V. Identification of isoflavone conjugates in red clover (Trifolium pratense) by liquid chromatography–mass spectrometry after two-dimensional solid-phase extraction. Anal. Chim. Acta 2001, 450, 81–97. [Google Scholar] [CrossRef]
  48. de Rijke, E.; Zappey, H.; Ariese, F.; Gooijer, C.; Brinkman, U.A.T. Flavonoids in leguminosae: Analysis of extracts of T. pratense L., T. dubium L., T. repens L., and L. corniculatus L. leaves using liquid chromatography with UV, mass spectrometric and fluorescence detection. Anal. Bioanal. Chem. 2004, 378, 995–1006. [Google Scholar] [CrossRef] [PubMed]
  49. Lemežienė, N.; Padarauskas, A.; Butkutė, B.; Cesevičienė, J.; Taujenis, L.; Norkevičienė, E. The concentration of isoflavones in red clover (Trifolium pratense L.) at flowering stage. Zemdirb.-Agric. 2015, 102, 443–448. [Google Scholar] [CrossRef] [Green Version]
  50. Mostrom, M.; Evans, T.J. Phytoestrogens. In Veterinary Toxicology—Basic and Clinical Principles, 2nd ed.; Gupta, R.C., Ed.; Elsevier: Amsterdam, The Netherlands, 2012; pp. 1012–1028. [Google Scholar]
  51. Butkute, B.; Lemežiene, B.; Dabkeviciene, G.; Jakštas, V.; Vilcinskas, E.; Janulis, V. Source of variation of isoflavone concentrations in perennial clover species. Pharmacogn. Mag. 2014, 10, S181–S188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Brandli, A.; Simpson, J.S.; Ventura, S. Isoflavones isolated from red clover (Trifolium pratense) inhibit smooth muscle contraction of the isolated rat prostate gland. Phytomedicine 2010, 17, 895–901. [Google Scholar] [CrossRef] [PubMed]
  53. Wu, Q.; Wang, M.; Simon, J.E. Determination of isoflavones in red clover and related species by high-performance liquid chromatography combined with ultraviolet and mass spectrometric detection. J. Chromatogr. A 2003, 1016, 195–209. [Google Scholar] [CrossRef]
  54. Klejdus, B.; Sterbova, D.; Stratil, P.; Kuban, V. Identification and characterization of isoflavones in plant material by HPLC-DAD-MS tandem. Chem. Listy 2003, 97, 530–539. [Google Scholar]
  55. Roby, M.H.H.; Abdelaliem, Y.F.; Esmail, A.H.M.; Mohdaly, A.A.A.; Ramadan, M.F. Evaluation of Egyptian honeys and their floral origins: Phenolic compounds, antioxidant activities, and antimicrobial characteristics. Environ. Sci. Pollut. Res. 2020, 27, 20748–20756. [Google Scholar] [CrossRef]
  56. Zhang, Z.; Liao, L.; Moore, J.; Wu, T.; Wang, Z. Antioxidant phenolic compounds from walnut kernels (Juglans regia L.). Food Chem. 2009, 113, 160–165. [Google Scholar] [CrossRef]
  57. Massei, G.; Cotterill, J.V.; Coats, J.C.; Bryning, G.; Cowan, D.P. Can batesian mimicry help plants to deter herbivores? Pest Manag. Sci. 2007, 63, 559–563. [Google Scholar] [CrossRef] [PubMed]
  58. Hughes, M.A. The cyanogenic polymorphism in Trifolium repens L. (white clover). Heredity 1991, 66, 105–115. [Google Scholar] [CrossRef] [Green Version]
  59. Bown, D. Encyclopaedia of Herbs and Their Uses; Dorling Kindersley: London, UK, 1995. [Google Scholar]
  60. Sabudak, T.; Guler, N. Trifolium L.—A review on its phytochemical and pharmacological profile. Phytother. Res. 2009, 23, 436–439. [Google Scholar] [CrossRef]
  61. Rassi, C.M.; Lieberherr, M.; Chaumaz, G.; Pointillart, A.; Cournot, G. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J. Bone Miner. Res. 2002, 17, 630–638. [Google Scholar] [CrossRef]
  62. Van de Wewijer, P.; Barentsen, R. Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002, 42, 187–193. [Google Scholar] [CrossRef]
  63. Wei, H.; Wei, L.; Bowen, R.; Frenkel, K.; Barnes, S. Inhibition of tumor promotion-induced hydrogen peroxide production in vitro and in vivo by genistein. Nutr. Cancer 1993, 20, 1–12. [Google Scholar] [CrossRef]
  64. Wei, H.; Bowen, R.; Cai, Q.; Barnes, S.; Wang, Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 1995, 208, 124–130. [Google Scholar] [CrossRef]
  65. Wei, H.C.; Cai, Q.Y.; Rahn, R.O. Inhibition of UV light- and fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis 1996, 17, 73–77. [Google Scholar] [CrossRef] [Green Version]
  66. Cai, Q.Y.; Wei, H.C. Effect of dietary genistein on antioxidant enzyme activities in Sencar mice. Nutr. Cancer 1996, 25, 1–7. [Google Scholar] [CrossRef]
  67. Widyarini, S.; Spinks, N.; Husband, J.A.; Reeve, E.V. Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation. Photochem. Photobiol. 2001, 74, 465–470. [Google Scholar] [CrossRef]
  68. Sowa, P.; Tarapatskyy, M.; Puchalski, C.; Jarecki, W.; Dżugan, M. A novel honey-based product enriched with coumarin from Melilotus flowers. J. Food Meas. Charact. 2019, 13, 1748–1754. [Google Scholar] [CrossRef] [Green Version]
  69. Venugopala, K.N.; Rashmi, V.; Odhav, B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed. Res. Int. 2013, 2013, 963248. [Google Scholar] [CrossRef] [Green Version]
  70. Kubrak, T.; Podgórski, R.; Stompor, M. Natural and synthetic coumarins and their pharmacological activity. Eur. J. Clin. Exp. Med. 2017, 15, 169–175. [Google Scholar] [CrossRef]
  71. Perrin, M.; Ramelet, A.A. Pharmacological treatment of primary chronic venous disease: Rationale, results and unanswered questions. Eur. J. Vasc. Endovasc. Surg. 2011, 41, 117–125. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Jasicka-Misiak, I.; Makowicz, E.; Stanek, N. Polish yellow sweet clover (Melilotus officinalis L.) honey, chromatographic fingerprints, and chemical markers. Molecules 2017, 22, 138. [Google Scholar] [CrossRef] [Green Version]
  73. Jerković, I. Volatile benzene derivatives as honey biomarkers. Synlett 2013, 24, 2331–2334. [Google Scholar] [CrossRef]
  74. Tan, S.T.; Holland, P.T.; Wilkins, A.L.; Molan, P.C. Extractives from New Zealand honeys. 1. White clover, manuka and kanuka unifloral honeys. J. Agric. Food Chem. 1988, 36, 453–460. [Google Scholar] [CrossRef]
  75. Zaghloul, O.A.; Nagda, A.A.E.; Nadia, M.H.; Moursi, M.; Maher, M.A. Chemical analysis of the Brazilian pepper, clover and citrus honeys produced by the honey bee workers, Apis mellifera L. (Hymenoptera: Apidae). J. Adv. Agric. Res. 2018, 21, 424–433. [Google Scholar] [CrossRef]
  76. Khalil, M.I.; Moniruzzaman, M.; Boukraâ, L.; Benhanifia, M.; Islam, M.A.; Islam, M.N.; Sulaiman, S.A.; Gan, S.H. Physicochemical and antioxidant properties of Algerian honey. Molecules 2012, 17, 11199–11215. [Google Scholar] [CrossRef] [Green Version]
  77. Islam, A.; Khalil, I.; Islam, N.; Moniruzzaman, M.; Mottalib, A.; Sulaiman, S.A.; Gan, S.H. Physicochemical and antioxidant properties of Bangladeshi honeys stored for more than one year. BMC Complement. Altern. Med. 2012, 12, 177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Can, Z.; Yildiz, O.; Sahin, H.; Turumtay, E.A.; Silici, S.; Kolayli, S. An investigation of Turkish honeys: Their physico-chemical properties, antioxidant capacities and phenolic profiles. Food Chem. 2015, 180, 133–141. [Google Scholar] [CrossRef] [PubMed]
  79. Shapla, U.M.; Solayman, M.; Alam, N.; Khalil, M.I.; Gan, S.H. 5-Hydroxymethylfurfural (HMF) levels in honey and other food products: Effects on bees and human health. Chem. Cent. J. 2018, 12, 35. [Google Scholar] [CrossRef] [PubMed]
  80. Morales, F.J. Hydroxymethylfurfural (HMF) and Related Compounds Process-Induced Food Toxicants: Occurrence, Formation, Mitigation, and Health Risks; Wiley: Hoboken, NJ, USA, 2008; pp. 135–174. [Google Scholar]
  81. Codex Alimentarius. International Food Standards: Standards for Honey; Codex Stan: Rome, Italy, 1981; Volume 11, pp. 1–8. [Google Scholar]
  82. Smetanska, I.; Alharthi, S.S.; Selim, K.A. Physicochemical, antioxidant capacity and color analysis of six honeys from different origin. J. King Saud Univ. Sci. 2021, 33, 101447. [Google Scholar] [CrossRef]
  83. Dunford, C.; Cooper, R.; Molan, P.; White, R. The use of honey in wound management. Nurs. Stand. 2000, 15, 63–68. [Google Scholar] [CrossRef]
  84. Lusby, P.E.; Coombes, A.; Wilkinson, J.M. Honey: A potent agent for wound healing? J. Wound Ostomy Cont. Nurs. 2002, 29, 295–300. [Google Scholar] [CrossRef]
  85. Abbas, H.A. Antibacterial, anti-swarming and antibiofilm activities of local Egyptian clover honey against Proteus mirabilis isolated from diabetic foot infection. Asian J. Pharm. Res. 2013, 3, 114–117. [Google Scholar]
  86. Khairy, E.A.; Hedia, R.H.; Dorgham, S.M.; Effat, M. Comparative studies on antimicrobial activities (AMA) of different types of honey using bacteria from animal origin. Int. J. Microbiol. Res. 2013, 4, 50–55. [Google Scholar]
  87. Hegazy, A.G. Antimicrobial activity of different Egyptian honeys as comparison of Saudi Arabia honey. Res. J. Microbiol. 2011, 6, 488–495. [Google Scholar] [CrossRef] [Green Version]
  88. Moghazy, A.M.; Shams, M.E.; Adly, O.A.; Abbas, A.H.; El-Badawy, M.A.; Elsakka, D.M.; Hassan, S.A.; Abdelmohsen, W.S.; Ali, O.S.; Mohamed, B.A. The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers. Diabetes Res. Clin. Pract. 2010, 89, 276–281. [Google Scholar] [CrossRef]
  89. El-Fadaly, H.; Abdilla, F.S.; El-Badrawy, E.E.Y. Comparative study between Yemeni and Egyptian types of honey by means of antibacterial activity. Pak. J. Biol. Sci. 1999, 2, 1–6. [Google Scholar]
  90. Radojčić, I.; Berković, K.; Kovač, S.; Vorkapić-Furač, J. Natural honey and black radish juice as tin corrosion inhibitors. Corros. Sci. 2008, 50, 1498–1504. [Google Scholar] [CrossRef]
  91. Rosliza, R.; Wan Nik, W.B.; Izman, S.; Prawoto, Y. Anti-corrosive properties of natural honey on Al–Mg–Si alloy in seawater. Curr. Appl. Phys. 2010, 10, 923–929. [Google Scholar] [CrossRef]
  92. Vrsalović, L.; Gudić, S.; Kliškić, M. Salvia officinalis L. honey as corrosion inhibitor for CuNiFe alloy in sodium chloride solution. Indian J. Chem. Technol. 2012, 19, 96–102. [Google Scholar]
  93. Gerengi, H.; Goksu, H.; Slepski, P. The inhibition effect of mad honey on corrosion of 2007-Type aluminium alloy in 3.5% NaCl solution. Mater. Res. 2014, 17, 255–264. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Basic Isoflavone structure.
Figure 1. Basic Isoflavone structure.
Foods 11 01901 g001
Figure 2. Structure of Irilone (a) and Pseudobaptigenin (b).
Figure 2. Structure of Irilone (a) and Pseudobaptigenin (b).
Foods 11 01901 g002
Figure 3. Basic Flavonoid structure.
Figure 3. Basic Flavonoid structure.
Foods 11 01901 g003
Figure 4. Basic structure of Hydroxycinnamic acid and its derivatives.
Figure 4. Basic structure of Hydroxycinnamic acid and its derivatives.
Foods 11 01901 g004
Figure 5. Basic structure of Hydroxybenzoic acid and its derivatives.
Figure 5. Basic structure of Hydroxybenzoic acid and its derivatives.
Foods 11 01901 g005
Figure 6. Structure of Catechin (a) and Ellagic acid (b).
Figure 6. Structure of Catechin (a) and Ellagic acid (b).
Foods 11 01901 g006
Figure 7. Volatile components reported in Clover plants.
Figure 7. Volatile components reported in Clover plants.
Foods 11 01901 g007
Figure 8. Volatile components found in Clover honey.
Figure 8. Volatile components found in Clover honey.
Foods 11 01901 g008
Figure 9. Miscellaneous compounds.
Figure 9. Miscellaneous compounds.
Foods 11 01901 g009
Figure 10. Volatile constituents of red clover honey.
Figure 10. Volatile constituents of red clover honey.
Foods 11 01901 g010
Figure 11. Structure of compounds reported in white clover honey.
Figure 11. Structure of compounds reported in white clover honey.
Foods 11 01901 g011
Table 1. Isoflavones reported in clover plants and honey (see Figure 1 for general structure).
Table 1. Isoflavones reported in clover plants and honey (see Figure 1 for general structure).
NameR5R6R7R2′R3′R4′
Biochanin A-OH-H-OH-H-H-O-Me
Formononetin-H-H-OH-H-H-O-Me
Daidzein-H-H-OH-H-H-OH
Glycitein-H-O-Me-OH-H-H-OH
Genistein-OH-H-OH-H-H-OH
Calycosin-H-OH-H-H-OH-O-Me
Prunetin-OH-H-O-Me-H-H-OH
Afrormosin-H-O-Me-OH-H-H-O-Me
Texasin-H-O-Me-O-Me-H-H-O-Me
Irilin B-OH-O-Me-OH-OH-H-H
IriloneN/AN/AN/AN/AN/AN/A
PseudobaptigeninN/AN/AN/AN/AN/AN/A
Legend: -H = hydride, -OH = hydroxide, -OMe = Methoxide.
Table 2. Flavonoids reported in clover plants and honey (see Figure 3 for general structure).
Table 2. Flavonoids reported in clover plants and honey (see Figure 3 for general structure).
NameR3R5R7R3′R4′R5′R6′
Quercetin-OH-OH-OH-H-OH-OH-H
Kaempferol-OH-OH-OH-H-OH-H-H
Morin-OH-OH-H-H-OH-H-OH
Myricetin-OH-OH-OH-OH-OH-OH-H
Pinocembrin-H-OH-OH-H-H-H-H
Legend: -H = hydride, -OH = hydroxide.
Table 3. Hydroxycinnamic acid and its derivatives reported in clover plants and honey (see Figure 4 for general structure).
Table 3. Hydroxycinnamic acid and its derivatives reported in clover plants and honey (see Figure 4 for general structure).
NameOR1R5R6R7
Caffeic acid-H-H-OH-OH
Rosmarinic acid-3,4-DHPLA-H-OH-OH
Chlorogenic acid-QA (3)-H-OH-OH
Cryptochlorogenic acid-QA (4)-H-OH-H
p-Coumaric acid-H-H-H-OH
Ferulic acid-H-H-O-Me-OH
Cinnamic acid-H-H-H-H
Legend: -H = hydride, -OH = hydroxide, -OMe = Methoxide, -QA = quinic acid.
Table 4. Hydroxybenzoic acid and its derivatives reported in clover plants and honey (see Figure 5 for general structure).
Table 4. Hydroxybenzoic acid and its derivatives reported in clover plants and honey (see Figure 5 for general structure).
NameOR1R3R4R5R6
Gallic acid-H-H-OH-OH-OH
Syringic acid-H-H-O-Me-OH-O-Me
p-Hydroxybenzoic acid-H-H-H-OH-H
m-Hydroxybenzoic acid-H-H-OH-H-H
Legend: -H = hydride, -OH = hydroxide, -OMe = Methoxide.
Table 5. Compounds reported in clover plants and clover honeys.
Table 5. Compounds reported in clover plants and clover honeys.
CategoryNameQuantity (Approximate)
Volatile components reported in clover plants(E)-3-Hexenyl acetateNot reported
(E)-3-hexenolNot reported
2-propanoneNot reported
2-butanoneNot reported
(E)-3-hexenalNot reported
1-octen-3-olNot reported
Volatile components found in Clover honeyβ-phellandrene2.17%
Benzenacetaldehyde5.84%
β-menthane2.23%
Thymol2.03%
Ethyl 2-(5-methyl-5-vinyltetrahydrofuran-2-yl) propan-2-ylcarbonate2.84%
Carophyllene11.23%
13-epimanool1.45%
Phenylacetic acid5.35–25.5%
p-eugenol6.54%
Phenylethyl alcohol2.03%
α-(phenylmethyl) benzenethanol6.44%
p-acetoxyanisole2.89%
N-butylbenzensulfonamide10.94%
Volatile constituents found in red clover honeyLilac aldehyde7.6–21.4%
Benzaldehyde7.0–15.7%
Octanoic acid0.7–2.9%
Nonanoic acidNot reported
Compounds reported in white clover honeyPalmitic acidNot reported
LignocericNot reported
OleicNot reported
α-linolenic acidNot reported
Succinic acidNot reported
OctanedioicNot reported
DecanedioicNot reported
2-decenedioic32.1 µg/g
Nonanedioic acidsNot reported
2-hydroxy-3-phenylpropionic acid2.5–66.9 µg/g
Benzoic acidNot reported
Miscellaneous compoundsCoumarin0.05 to 0.88 mg/kg
Lumichrome1.85%
Hydroxymethyl furfural10.73–77.13 mg/kg
Table 6. Bioactivities of various clover honeys.
Table 6. Bioactivities of various clover honeys.
Bioactivity Clover Honey Type
Antioxidant activityRed clover; Egyptian clover
Antimicrobial activityRed clover; Egyptian clover; Alsike clover
Wound healing activityEgyptian clover
Anti-corrosive activityRed clover
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sultana, S.; Foster, K.; Lim, L.Y.; Hammer, K.; Locher, C. A Review of the Phytochemistry and Bioactivity of Clover Honeys (Trifolium spp.). Foods 2022, 11, 1901. https://doi.org/10.3390/foods11131901

AMA Style

Sultana S, Foster K, Lim LY, Hammer K, Locher C. A Review of the Phytochemistry and Bioactivity of Clover Honeys (Trifolium spp.). Foods. 2022; 11(13):1901. https://doi.org/10.3390/foods11131901

Chicago/Turabian Style

Sultana, Sharmin, Kevin Foster, Lee Yong Lim, Katherine Hammer, and Cornelia Locher. 2022. "A Review of the Phytochemistry and Bioactivity of Clover Honeys (Trifolium spp.)" Foods 11, no. 13: 1901. https://doi.org/10.3390/foods11131901

APA Style

Sultana, S., Foster, K., Lim, L. Y., Hammer, K., & Locher, C. (2022). A Review of the Phytochemistry and Bioactivity of Clover Honeys (Trifolium spp.). Foods, 11(13), 1901. https://doi.org/10.3390/foods11131901

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop